Though we have effective AOM in our armamentarium, such as phentermine, extended-release naltrexone and bupropion, and liraglutide, their more modest weight loss (mean total 4% to 8%) 1 and/or side-effect profiles often preclude their use
Subcutaneous administration of vitamin B12 is sometimes employed, especially in patients with congenital cobalamin metabolism disorders who require high doses to maintain normal metabolic pathways
Why This Question Comes Up The stacking question is intuitive: if one GLP-1 compound drives weight loss, wouldn't two drive more
Mold toxicity is a hidden epidemic, silently affecting countless individuals who struggle with unexplained symptoms
Variation in Candida albicans EFG1 expression enables host-dependent changes in colonizing fungal populations
Require Stability Data: Supplier should provide evidence of product stability under recommended storage conditions (e.g., refrigeration)